Search
Patexia Research
Case number 3:24-cv-04317

INTRA-CELLULAR THERAPIES, INC. v. HETERO USA, INC. et al > Summary

Court Case Number 3:24-cv-04317

Filing Date Mar 28, 2024

Court New Jersey District Court

Status Unknown

JudgesMichael A. Shipp

Plaintiff

Intra-Cellular Therapies, Inc.

Defendant

Hetero

Related Patents

Doc No Title Issue date
11806348 Methods of treatment using pharmaceutical capsule compositions comprising lumateperone mono-tosylate Nov 7, 2023
11753419 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3'4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders Sep 12, 2023
11690842 Pharmaceutical capsule compositions comprising lumateperone mono-tosylate Jul 4, 2023
RE048839 Methods and compositions for sleep disorders and other disorders Dec 7, 2021
11052084 Pharmaceutical capsule compositions comprising lumateperone mono-tosylate Jul 6, 2021
11026951 Methods of treating bipolar disorder Jun 8, 2021
10960009 Methods of treating schizophrenia and depression Mar 30, 2021
10695345 Pharmaceutical capsule compositions comprising lumateperone mono-tosylate Jun 30, 2020
09956227 Method for the treatment of residual symptoms of schizophrenia May 1, 2018
08648077 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid addition salt and salt crystals Feb 11, 2014
Menu